通心络胶囊治疗冠心病心绞痛症状的研究进展

doi:10.3969/j.issn.1674-490X.2016.03.011

摘要/Abstract

摘要： 随着中国人口老龄化的进展,冠心病的发病率逐渐提升。而心绞痛是冠心病的一个重要症状,中国临床上常用于控制心绞痛的药物有β受体阻滞剂、钙通道阻滞剂及硝酸酯类药物,除此之外还有通心络胶囊。通过一系列的临床试验和研究发现通心络具有一定的疗效,能够有效地改善和缓解冠心病心绞痛患者的症状,并且安全性较高,能够降低由于大剂量使用西药带来的副作用,值得在临床上推广使用。

关键词: 冠心病, 通心络胶囊, 临床疗效

Abstract: With the development of China's population aging,the incidence rate of coronary heart disease is gradually increasing.Angina pectoris is an important symptom of coronary heart disease.In China,it is commonly used in the control of angina pectoris with beta blockers,calcium channel blockers and nitrates.Besides,it also has the traditional Chinese medicine Tongxinluo capsule.At present,through a series of clinical trials and research findings indicated that it has a certain efficacy and safety,which can effectively improve and ease coronary heart disease patients with angina pectoris,reduce the side effect caused by large doses of medicine,it is worth promoting in clinical use.

Key words: coronaryheart disease, Tongxinluo capsule, clinical efficacy

中图分类号:

黄雅琴,夏月平,牛培. 通心络胶囊治疗冠心病心绞痛症状的研究进展[J]. 医学研究与教育, 2016, 33(3): 52-56.

HUANG Yaqin,XIA Yueping,NUI Pei. Advances on the treatment of angina pectoris symptoms of coronary heart disease with Tongxinluo capsule[J]. Medical Reserch and Education, 2016, 33(3): 52-56.

参考文献

[1] 张晓琳,薛均来.通心络胶囊治疗糖尿病合并冠心病患者118例的临床观察与分析[J].糖尿病新世界,2014,34(23):29.DOI:10.16658/j.cnki.1672-4062.2014.23.004.
[2] JOHN F,ASCHENBRENNER T,FELGENDREHER R,et al.Treatment of coronary three-vessel disease in patients above 75 years[J].Dtsch Med Wochenschr,2016,141(6):e53-e59.DOI:10.1055/s-0041-108248.Epub 2016 Mar 16.
[3] 李烈.冠心病的病理学[J].广医通讯,1976(4):34-38.
[4] 吴限,李延,徐国峰,等.心脑通络液治疗冠心病心绞痛的临床研究[D].黑龙江中医药大学,2002,29(2):3-13.DOI: 10.3969/j.issn.1002-2392.2001.02.004.
[5] WANG Z T,WANG Z,HU Y W.Possible roles of platelet-derived microparticles in atherosclerosis[J].Atherosclerosis,2016,248:10-16.DOI:10.1016/j.atherosclerosis.2016.03.004.Epub 2016 Mar 4.
[6] PARK Y,FRANCHI F,ROLLINI F,et al.Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease[J].Circ J,2016,80(4):791-801.DOI:10.1253/circj.CJ-16-0208.Epub 2016 Mar 16.
[7] 刘辉.雷诺嗪缓释片在Beagle大体内药物代谢动力学研究[D].成都:成都中医药大学,2010.
[8] MÖBIUS-WINKLER S,UHLEMANN M,ADAMS V,et al.Coronary Collateral Growth Induced by Physical Exercise:Results of the Leipzig EXerCIse Training versus MEdica Management in Patients With Stable Coronary Artery Artery(EXCITE)Trial[J].Circulation,2016,Mar 15.[Epub ahead of print].DOI:10.1177/2050640614548980.
[9] 孙枫.中西医结合治疗冠心病心绞痛80例临床可行性分析[J].心血管病防治知识月刊,2015(7):47-48.
[10] 董武松,李馨欣,杨俊.内皮素-1在心血管系统中的作用[J].国际心血管病杂志,2012, 39(3):153-156.
[11] 张冰睿.通心络胶囊对心肌缺血大鼠血管新生功能的影响[J].泰山医学院学报,2015,36(6):636-639. DOI:10.3969/j.issn.1004-7115.2015.06.012.
[12] SECKIN S,EMRAH B,BIYIK I,et al.786T/c endothelial nitric oxide synthase gene polymorphism and coronary collateral circulation[J].Postepy Hig Med Dosw(Online),2016,70:80-85.DOI:10.5604/17322693.1194619.
[13] 张芳,任开涵,陈玉林,等.通心络胶囊对冠状动脉慢性完全闭塞病变患者血瘀征象及血管新生的影响[J].中国临床药理学杂志,2015,31(10):793-795.DOI:10.13699/j.cnki.1001-6821.2015.10.008.
[14] 钟永豪.通心络胶囊联合阿托伐他汀钙治疗高血压伴高血脂的有效性和安全性研究[J].内蒙古中医药,2015,34(5):18.
[15] 罗俊勇,罗献伦.通心络胶囊治疗急性冠脉综合征及对高敏C反应蛋白的影响[J].内蒙古中医药,2015,34(8):29.
[16] 马锐,李瑞雪,夏丽芳,等.通心络胶囊对早期糖尿病肾病患者血管内皮功能及肾功能的影响[J].疑难病杂志,2015,14(9):884-887. DOI:10.3969/j.issn.1671-6450.2015.09.002.
[17] 邵珊.通心络胶囊治疗糖尿病心肌病的临床观察[J].糖尿病新世界,2015,35(13):31-32.
[18] 胡战云.通心络胶囊联合曲美他嗪治疗不稳定型心绞痛效果分析[J].河南医学研究,2015,24(6):94-95.DOI:10.3969/j.issn.1004-437X.2015.06.053.
[19] 李海洲,王瑾.心肌缺血患者应用通心络胶囊联合曲美他嗪治疗的临床效果评价[J].中国医药指南,2015,13(21):180-181.
[20] 孙艳.通心络胶囊与复方丹参片治疗冠心病心绞痛效果的临床观察和比较[J].中国医药指南,2015,13(20):219-220.
[21] 唐菲,於建鹏.通心络胶囊治疗脑卒中合并急性冠脉综合征的免疫机制研究[J].中国实用神经疾病杂志,2015,18(17):32-33.
[22] 樊蓉,任天舒,赵庆春.西药常规治疗联用通心络胶囊治疗冠心病心绞痛疗效的荟萃分析[J].药学实践杂志,2015,33(1):83-87. DOI:10.3969/j.issn.1006-0111.2015.01.024.
[23] 王超,张会欣,邢邯英,等.通心络胶囊对糖尿病周围神经病变模型小鼠炎症因子的影响[J].中国药房,2015,26(19):2621-2624.
[24] 段波.阿托伐他汀联合通心络对冠心病不稳定性心绞痛疗效及血脂的影响[J].中国处方药,2015,13(7):58-59.
[25] 刘圣君,赵自刚,刘艳凯,等.通心络胶囊对原发肾病综合征患者血流流变学指标及血管活性物质的调节作用[J].中国临床康复,2006,10(7):70-72.
[26] 李娟.通心络胶囊治疗颈动脉粥样硬化斑块146例临床观察[J].中国伤残医学,2015,23(14):24-25.DOI:10.13214/j.cnki.cjotadm.2015.14.014.
[27] 孟岳祥.通心络联合生脉注射液治疗慢性心力衰竭效果观察[J].中国乡村医药,2015,22(18):30-31.
[28] 杨竞霄,滕继伟,李雪.通心络胶囊联合氨氯地平及复方盐酸阿米洛利逆转高血压左室肥厚的临床效果[J].疑难病杂志,2015,14(9):881-883. DOI:10.3969/j.issn.1671-6450.2015.09.001.
[29] 周忠冉,唐海沁,李结华,等.通心络胶囊治疗冠心病疗效及安全性的系统评价[J].中国循证医学杂志, 2011,11(9):1078-1083.DOI:10.3969/j.issn.1672-2531.2011.09.016.